ArticleMedicina (Kaunas, Lithuania)2023

Visfatin and Subclinical Atherosclerosis in Type 2 Diabetes: Impact of Cardiovascular Drugs.

Kati Kärberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.